Mar 10, 2026 Diabetes, GLP-1 Agonist Therapy Center, Obesity, Obesity, Type 2 Diabetes, Type 2 Diabetes 2,154 views Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the management of type 2 diabetes and obesity
In some patients, one medicine may offer a more suitable balance between glucose lowering, appetite reduction, and side effects
Prof Jason Halford, president of the European Association for the Study of Obesity, said that as the medication could be seen to improve cardiovascular health, it could be economically beneficial for it to be prescribed widely
Welch MD, M.S.P.H., FACPM, ABAARM AgeMD is here to help you feel like yourself again, stronger, clearer, and in control. Health isnt one size fits all